Ryan Brown

2021

In 2021, Ryan Brown earned a total compensation of $5.1M as Senior Vice President General Counsel at Sarepta Therapeutics.

Compensation breakdown

Non-Equity Incentive Plan$260,820
Option Awards$2,959,290
Salary$473,550
Stock Awards$1,306,650
Other$103,980
Total$5,104,290

Brown received $3M in option awards, accounting for 58% of the total pay in 2021.

Brown also received $260.8K in non-equity incentive plan, $473.6K in salary, $1.3M in stock awards and $104K in other compensation.

Rankings

In 2021, Ryan Brown's compensation ranked 2,557th out of 12,415 executives tracked by ExecPay. In other words, Brown earned more than 79.4% of executives.

ClassificationRankingPercentile
All
2,557
out of 12,415
79th
Division
Manufacturing
1,016
out of 5,501
82nd
Major group
Chemicals And Allied Products
391
out of 2,371
84th
Industry group
Drugs
342
out of 2,092
84th
Industry
Pharmaceutical Preparations
224
out of 1,542
86th

Pay ratio

Ryan Brown's Pay$5,104,290
Median Employee's Pay$271,908
Pay Ratio

19

to 1

In 2021, the annual total compensation of Ryan Brown was $5,104,290.

The annual total compensation of the median employee at Sarepta Therapeutics was $271,908.

The ratio of Ryan Brown's pay to the pay of median employee was therefore 19 to one.

Source: SEC filing on April 25, 2022.

Brown's colleagues

We found four more compensation records of executives who worked with Ryan Brown at Sarepta Therapeutics in 2021.

2021

Louise Rodino-Klapac

Sarepta Therapeutics

Chief Scientific Officer

2021

Ian Estepan

Sarepta Therapeutics

Chief Financial Officer

2021

William Ciambrone

Sarepta Therapeutics

Executive Vice President, Technical Operations

2021

Douglas Ingram

Sarepta Therapeutics

Chief Executive Officer

News

In-depth

You may also like